Submit Your Feeds

Business News • PR NewsWire • Abbott Statement: ACCORD Lipid Results Support Treatment Guidelines for Fibrate Use

Abbott Statement: ACCORD Lipid Results Support Treatment Guidelines for Fibrate Use
Abbott Statement: ACCORD Lipid Results Support Treatment Guidelines for Fibrate Use

ATLANTA, March 14 /PRNewswire-FirstCall/ -- Results were presented today on behalf of the National Heart, Lung and Blood Institute from ACCORD, a study in patients with diabetes that evaluated cardiovascular outcomes in three distinct studies – glycemic control, blood pressure control and lipi

View More : http://www.prnewswire.com/news-releases/abbott-statement-accord-lipid-results-support-treatment-guidelines-for-fibrate-u...
Releted News by prnewswire
New Data Demonstrates Abbott's Investigational MitraClip(R) System Has Potential to be a Valuable Treatment Option for Patients With Mitral Regurgitation, the Most Common Heart Valve Condition
Abbott Statement: ACCORD Lipid Results Support Treatment Guidelines for Fibrate Use
NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance
Siemens Highlights Its Commitment to Excellence in Cardiology at ACC 2010
Asian Pacific American Municipal Officials Constituency Group Elects New Officers
Home Sitemap Contact Us
© businessNewsNewsNews.com